Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06560476 · ClinicalTrials.gov registry record

OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

A clinical trial of Benign Prostatic Hyperplasia, sponsored by Urotronic.

Recruiting
Registry status
500
Enrollment target
9
Study locations

NCT06560476 is a study of Benign Prostatic Hyperplasia that is actively recruiting participants, run by Urotronic. The registered enrollment target is 500 participants, roughly in line with the 535-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target. The trial reports 9 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06560476, a study of Benign Prostatic Hyperplasia, is actively recruiting participants, sponsored by Urotronic.

RECRUITING
Registry status
500 participants
Enrollment target
9
Study locations

Study Summary

APEX is a prospective multi-site registry of real-world experience with the Optilume™ BPH Catheter System for treatment of men experiencing symptomatic BPH.

Conditions Studied

Benign Prostatic Hyperplasia

Interventions

  • OTHER Data collection

Study Locations (9)

Nebraska

  • Kearney Urology Center - Kearney
  • The Urology Center, P.C. - Omaha

California

  • Golden State Urology - Sacramento

Florida

  • Florida Urology Partners - Tampa

Nevada

  • Sheldon Freedman, Ltd - Las Vegas

New York

  • Northwell Health - Smith Institute of Urology - Syosset

Oregon

  • Good Samaritan Hospital - Corvallis

Texas

  • Midtown Urology - Austin

Virginia

  • Potomac Urology - Woodridge

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2024-03-30
Est. Completion 2027-03-30

Sponsor

Urotronic

8 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06560476

The ClinicalTrials.gov registry entry for NCT06560476 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 535-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target. The listed sponsor is Urotronic, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 1 intervention - of which Data collection is the first listed.

NCT06560476 reports 9 study locations spanning 8 distinct geographic areas - top geographies include Nebraska, California, Florida.

Frequently Asked Questions

What is clinical trial NCT06560476 about?

NCT06560476 is a clinical study titled "OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH". APEX is a prospective multi-site registry of real-world experience with the Optilume™ BPH Catheter System for treatment of men experiencing symptomatic BPH.

What is the current status of trial NCT06560476?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-03-30. Estimated completion is 2027-03-30.

What conditions does trial NCT06560476 study?

This clinical trial studies the following conditions: Benign Prostatic Hyperplasia.

What interventions are being tested in trial NCT06560476?

The interventions under investigation include: Data collection (OTHER).

Who is sponsoring clinical trial NCT06560476?

This trial is sponsored by Urotronic, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06560476 being conducted?

This trial has 9 study locations across California, Florida, Nebraska, Nevada, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Benign Prostatic Hyperplasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Benign Prostatic Hyperplasia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.